Australia Approves Roche Targeted Drug For Advanced Melanoma
This article was originally published in PharmAsia News
Executive Summary
Australian drug authorities approved Roche's Zelboraf (vemurafenib) for certain cases of advanced melanoma, but the Pharmaceutical Benefits Scheme has yet to agree to cover its cost to patients.